Promimic AB (publ) (STO:PRO)
Sweden · Delayed Price · Currency is SEK 13.20
+2.20 (20.00%)
Mar 2, 2026, 12:47 PM CET
Promimic AB Revenue
In the year 2025, Promimic AB had annual revenue of 52.73M SEK with 7.82% growth. Promimic AB had revenue of 13.26M in the quarter ending December 31, 2025, a decrease of -12.36%.
Revenue
52.73M
Revenue Growth
+7.82%
P/S Ratio
4.73
Revenue / Employee
2.93M
Employees
18
Market Cap
249.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.73M | 3.83M | 7.82% |
| Dec 31, 2024 | 48.91M | 9.70M | 24.73% |
| Dec 31, 2023 | 39.21M | 22.14M | 129.65% |
| Dec 31, 2022 | 17.07M | 9.01M | 111.65% |
| Dec 31, 2021 | 8.07M | 2.46M | 43.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 489.70M |
| Mentice AB | 284.59M |
| Arcoma AB | 130.80M |
| Integrum AB | 102.58M |
| BrainCool AB | 38.69M |
| SciBase Holding AB | 36.59M |
| Nosa Plugs AB | 24.12M |
| Episurf Medical AB | 20.20M |